Pierre Troisfontaines

Acetazolamide in Acute Decompensated Heart Failure with Volume Overload

Wilfried Müllens, Jeroen Dauw, Pieter Martens et al. · New England Journal of Medicine · 2022 · 550 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Prognostic Importance of Exercise-Induced Changes in Mitral Regurgitation in Patients With Chronic Ischemic Left Ventricular Dysfunction

Patrizio Lancellotti, Pierre Troisfontaines, Anne-Christine Toussaint et al. · Circulation · 2003 · 305 citations

Medicine, Cardiology, Physiology +17

Effect of a Telemonitoring-Facilitated Collaboration Between General Practitioner and Heart Failure Clinic on Mortality and Rehospitalization Rates in Severe Heart Failure: The TEMA-HF 1 (Telemonitoring in the Management of Heart Failure) Study

Paul Dendale, Gilles W. De Keulenaer, Pierre Troisfontaines et al. · European Journal of Heart Failure · 2011 · 249 citations · Full text

Medicine, Cardiology, Internal Medicine +10

Rationale and Design of the Advor (Acetazolamide in Decompensated Heart Failure with Volume Overload) Trial

Wilfried Müllens, Frederik H. Verbrugge, Petra Nijst et al. · European Journal of Heart Failure · 2018 · 97 citations · Full text

Medicine, Cardiology, Pharmacology +10

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13